Heart Disease Trial, Recruiting NCT07613996 Sponsor: Shanghai Zhongshan Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07613996
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have stable chest pain (angina) or are suspected of having coronary heart disease (a condition affecting the blood vessels of the heart).
  • People who are already scheduled to have a coronary angiography (a procedure that takes images of the heart's blood vessels) along with a pressure-based blood flow test.
  • People whose target heart vessel shows either less than 50% blockage, or between 50–90% blockage with a blood flow pressure reading (called FFR) above 0.80, indicating the blockage is not severely restricting blood flow.
  • People who have given their written agreement (informed consent) to take part in the trial.

Who may not be able to join:

  • People whose heart or circulation is currently unstable, such as those experiencing a heart attack, heart failure shock, or a serious irregular heartbeat.
  • People for whom an angiography procedure would not be safe, such as those with severe kidney failure (confirm with trial site for other contraindications).
  • People for whom adenosine (a medication used during the blood flow test) would not be safe, such as those with severe asthma or certain serious heart rhythm conditions affecting the electrical signals between the upper and lower chambers of the heart.
  • People with a life expectancy of less than one year, or people who are pregnant.
  • People whose target heart vessel is not suitable for the procedure — for example, if it is the left main artery, is severely twisted or curved, or has a blockage greater than 90%.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 021 6404 1990

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 May 2026
Est. completion
31 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Area Under the ROC Curve (AUC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov